UF Professor Emeritus Receives Hungarian Recognition of Merit & Science
Nicholas Bodor, Ph.D., D.Sc., Graduate Research Professor Emeritus (active) at the UF College of Pharmacy, in 20011, received high honors from his native country, Hungary in recognition of his global scientific accomplishments.
In August, the Hungarian government recognized Bodor at its official ceremony in Budapest. Bodor received the Commander’s Cross of the Order of Merit of the Hungarian Republic, a prestigious state award of civil merit. He received the cross at an official ceremony in the Hungarian parliament on the eve of the August 20th national celebration of Hungary’s canonized first king, St. Stephen. Bodor also received the complemental pin, the Knight’s Cross of the Order of Merit and an ornate diploma summarizing his accomplishments. Previously, in 2004, he received the Gold Cross of Merit of the Hungarian Republic.
UF recruits FDA senior scientist to advance Florida’s drug development, regulatory science efforts
A leading scientist in clinical pharmacology at the Food and Drug Administration is taking a new academic role at the University of Florida College of Pharmacy to improve drug development and create tools and approaches to make sure new products are safe, effective and within FDA-regulated standards.
Lawrence J. Lesko, Ph.D., director of the Office of Clinical Pharmacology at the FDA’s Center for Drug Evaluation and Research, will lead the college’s new pharmacometrics and systems pharmacology initiative in the interdisciplinary Institute of Therapeutic Innovation at the UF Research and Academic Center, now under construction in Orlando.
Distinguished Professor Earns Double Recognition in Drug Development
The process of bringing one new drug to market can take a decade and hundreds of millions of dollars. Hartmut Derendorf, a distinguished professor in the UF College of Pharmacy, is finding ways to tighten expenses and shorten timelines while balancing patient variability, drug safety and effectiveness against all possible risks. His work was recognized by two national pharmacy organizations this year.
In July he received the 2010 Volwiler Research Achievement Award from the American Association of Colleges of Pharmacy at its annual meeting in Seattle.
“Dr. Derendorf is an exceptional leader and teacher. He is not only known for his incredible contributions to pharmaceutical education, but for his leadership and mentorship to advance research that is vital to the academic community,” said Lucinda L. Maine, Ph.D., R.Ph., AACP executive vice president and CEO, when she presented the award.